Home »  Topic »  Inovio’s COVID-19 vaccine shows encouraging early results, joins Trump’s ‘Warp Speed’

Inovio’s COVID-19 vaccine shows encouraging early results, joins Trump’s ‘Warp Speed’


Plymouth Meeting, Pa: Inovio Pharmaceuticals, a US biotech firm, on Tuesday reported that its experimental vaccine against the novel coronavirus (SARS-CoV-2) has shown encouraging results in a small preliminary trial. The firm claimed that its INO-4800, a DNA vaccine against COVID-19, triggered an immune response in 94 per cent of volunteers who completed the phase 1 clinical trial. Inovio now plans to initiate a Phase 2/3 trial to assess the efficacy of the vaccine this summer upon regulatory concurrence.

In a press release, Inovio also said that its INO-4800 has been selected to participate in a non-human primate (NHP ...


Read the full text TimesNow